Posted on 24/08/202413/09/2024 by Pencis Mrs. Jelena Kovacic | New Drug Development | Best Researcher Award Faculty of Pharmacy and Biochemistry University of Zagreb | Croatia Author Profile Scopus ORCID ID Google Scholar šEARLY ACADEMIC PURSUITSĀ Jelena KovaÄiÄ embarked on her academic journey with a Master of Science in Applied Chemistry from the Faculty of Chemical Engineering and Technology in Zagreb, completed in 2021. Her master’s thesis focused on the monitoring of degradation of selected active substances, laying a solid foundation for her research career. š¬PROFESSIONAL ENDEAVORSĀ Jelena is currently a Ph.D. researcher at the Faculty of Pharmacy and Biochemistry, University of Zagreb. Her work primarily involves developing advanced analytical methods for drugs and biologically active substances, specifically targeting treatments for inflammatory bowel disease. Her role also includes involvement in stability-indicative methods, compatibility studies, and therapeutic drug monitoring. š§ŖCONTRIBUTIONS AND RESEARCH FOCUS ON NEW DRUG DEVELOPMENT Jelenaās research contributions are centered around preformulation studies, including forced degradation studies and compatibility assessments. She is also engaged in bioanalytical research, focusing on therapeutic drug monitoring and microextraction techniques. Her work involves advanced analytical techniques such as liquid chromatography (LC), mass spectrometry (MS), and chemometrics. šIMPACT AND INFLUENCEĀ Through her active participation in international symposia and congresses, Jelena has contributed to the broader scientific community’s understanding of analytical methods and bioanalytical techniques. Her research aims to enhance the efficacy and safety of drug treatments, particularly in the context of inflammatory bowel diseases. šACADEMIC CITATIONSĀ Jelena has established a growing presence in the academic community with her research contributions and presentations at various international platforms. Her work is expected to garner more citations as she progresses in her doctoral studies and publishes her findings. š®LEGACY AND FUTURE CONTRIBUTIONSĀ Jelena KovaÄiÄ’s future contributions are anticipated to make a significant impact on the field of pharmaceutical sciences. With her expertise in developing advanced analytical methods and her dedication to research in drug treatments, she is poised to advance the understanding and application of these methods in clinical settings, thereby shaping future research and development in the field. šÆConclusion Jelena KovaÄiÄ is an emerging researcher with a strong foundation in applied chemistry and a promising trajectory in pharmaceutical sciences. Her academic pursuits and professional experiences reflect a deep commitment to advancing analytical methods and bioanalytical techniques, particularly in the treatment of inflammatory bowel disease. Through her work, she contributes valuable insights into drug development and stability, enhancing the field’s overall knowledge and application. Her active participation in international forums and her ongoing research efforts position her as a future leader in pharmaceutical research, with the potential to significantly influence drug treatment methodologies and improve patient outcomes. As she continues to develop her expertise, Jelena is set to leave a lasting impact on the scientific community šš¬NOTABLE PUBLICATION: Polyphenol content and antioxidant activity of phytoestrogen containing food and dietary supplements: DPPH free radical scavenging activity by HPLC Authors: KlariÄ, D.A., Mornar, A., KovaÄiÄ, J., BrletiÄ, I., KlariÄ, I. Journal: Acta Pharmaceutica Year: 2022 Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease Authors: JeliÄiÄ, M.-L., AmidžiÄ KlariÄ, D., KovaÄiÄ, J., Verbanac, D., Mornar, A. Journal: Pharmaceuticals Year: 2022 Green Solid-Phase (Micro)Extraction of Andrographolides from Human Plasma Samples Followed by UHPLC-DAD-QqQ-MS/MS Analysis Authors: KovaÄiÄ, J., JeliÄiÄ, M.-L., AmidžiÄ KlariÄ, D., Mornar, A. Journal: Separations Year: 2023 Antioxidant Activity of Pharmaceuticals: Predictive QSAR Modeling for Potential Therapeutic Strategy Authors: JeliÄiÄ, M.-L., KovaÄiÄ, J., CvetniÄ, M., Mornar, A., KlariÄ, D.A. Journal: Pharmaceuticals Year: 2022 Size exclusion chromatography as green support for forced degradation study of adalimumab Authors: KovaÄiÄ, J., KlariÄ, D.A., Turk, N., Mornar, A. Journal: Acta Pharmaceutica Year: 2023 Mrs. Jelena Kovacic | New Drug Development | Best Researcher Award